Oak Family Advisors LLC Has $6.44 Million Position in Stryker Corporation $SYK

Oak Family Advisors LLC boosted its holdings in Stryker Corporation (NYSE:SYK) by 569.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 19,610 shares of the medical technology company’s stock after acquiring an additional 16,682 shares during the period. Stryker accounts for 1.8% of Oak Family Advisors LLC’s holdings, making the stock its 21st biggest position. Oak Family Advisors LLC’s holdings in Stryker were worth $6,444,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Sankala Group LLC acquired a new position in shares of Stryker in the fourth quarter valued at $26,000. Godfrey Financial Associates Inc. acquired a new stake in shares of Stryker during the 4th quarter worth about $26,000. United Financial Planning Group LLC bought a new stake in shares of Stryker during the 3rd quarter worth about $27,000. Atlas Capital Advisors Inc. acquired a new position in Stryker in the 4th quarter valued at about $27,000. Finally, DJE Kapital AG acquired a new position in Stryker in the 4th quarter valued at about $28,000. 77.09% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on SYK shares. Truist Financial restated a “hold” rating and set a $330.00 price objective (down from $380.00) on shares of Stryker in a research report on Monday, May 4th. Barclays decreased their target price on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research report on Monday, May 4th. Sanford C. Bernstein set a $410.00 target price on Stryker in a research note on Friday, May 1st. Canaccord Genuity Group reduced their price target on Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Finally, Needham & Company LLC decreased their price objective on Stryker from $454.00 to $418.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Stryker presently has an average rating of “Moderate Buy” and an average price target of $395.33.

Insider Buying and Selling

In other Stryker news, VP Robert S. Fletcher sold 4,544 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president directly owned 10,582 shares in the company, valued at $3,247,298.34. This represents a 30.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP M Kathryn Fink sold 3,500 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.45, for a total transaction of $992,075.00. Following the completion of the transaction, the vice president directly owned 177 shares in the company, valued at approximately $50,170.65. This represents a 95.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 323,264 shares of company stock valued at $100,659,489 over the last quarter. 4.60% of the stock is owned by company insiders.

Stryker Stock Up 1.2%

NYSE SYK opened at $313.87 on Thursday. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62. The company has a market cap of $120.32 billion, a price-to-earnings ratio of 36.33, a PEG ratio of 1.99 and a beta of 0.78. The company has a 50 day moving average of $311.87 and a 200-day moving average of $340.32. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.Stryker’s revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the business earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts expect that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s payout ratio is 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.